Company news
Sensei Biotherapeutics, Inc. news in 2022
Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Sensei Biotherapeutics Provides Update on Strategic Priorities
December 7, 2022
Sensei Biotherapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
Sensei Biotherapeutics Announces Collaboration with Washington University, St. Louis to Support Development of SNS-101, a Conditionally Active VISTA-blocking Antibody
November 20, 2022
Sensei Biotherapeutics Presents Preclinical Data at the 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 9, 2022
Sensei Biotherapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
November 7, 2022
Sensei Biotherapeutics to Host Virtual Key Opinion Leader Webinar, “Lessons from VISTA: New Strategies to Address an Important Immune Checkpoint”
November 6, 2022
Sensei Biotherapeutics to Participate in the 13th Annual Jefferies Global Healthcare Conference
November 1, 2022
Sensei Biotherapeutics to Present New Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
October 4, 2022
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
September 29, 2022
Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
September 20, 2022
Sensei Biotherapeutics Announces New Preclinical Data Demonstrating Favorable Pharmacokinetic and Immunologic Effects of SNS-101, a pH-selective VISTA-blocking Antibody
August 30, 2022
Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
August 8, 2022
Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer
May 31, 2022
Sensei Biotherapeutics to Participate in Jefferies Healthcare Conference
May 24, 2022
Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 9, 2022
Sensei Biotherapeutics Reports Full Year 2021 Financial Results and Business Highlights
March 9, 2022
Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors
March 8, 2022
Sensei Biotherapeutics to Participate in the 32nd Annual Oppenheimer Healthcare Conference
March 2, 2022
Sensei Biotherapeutics to Participate in Citi’s 2022 Virtual Immuno-Oncology Summit
February 10, 2022
Sensei Biotherapeutics Announces Executive Promotions
January 5, 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 31 slides · Nov 8, 2022
- Investor Presentation (August 2022)
Investor deck · 26 slides · Aug 31, 2022
- Investor Presentation (August 2022)
Investor deck · 26 slides · Aug 9, 2022
- World Vaccine Congress 2022
Conference · 24 slides · Apr 20, 2022
- JP Morgan Healthcare Conference 2022
Conference · 33 slides · Jan 10, 2022